Is sentinel lymph node biopsy appropriate in patients with thin melanomas: Too early to tell?

Annals of Surgical Oncology

Volumn 13, Issue 3, 2006, Pages 279-281

  Thompson, John F ^a,b   Shaw, Helen M ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; LYMPH NODE DISSECTION; MEDICAL LITERATURE; MELANOMA; METASTASIS; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY;

HUMANS; MELANOMA; NEOPLASM STAGING; PROGNOSIS; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 32844460356     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2006.08.927     Document Type: Editorial

References (11)

1. Morton DL, Thompson JF, Cochran AJ, Essner R, Elashoff R. Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma. (ASCO abstract 7500). J Clin Oncol 2005; 23(16 Suppl):710.
2. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. Lancet 1998; 351:793-6.
3. Carlson GW, Murray DR, Hestley A, et al. Sentinel lymph node mapping for thick (> = 4-mm) melanoma: should we be doing it? Ann Surg Oncol 2003; 10:408-15.
4. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry, the Sydney Melanoma Unit. Cancer 2003; 98:1223-31.
5. Wong SL, Brady MS, Busam KJ, Coit DG. Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol 2006; 13 (in press).
6. Olah J, Gyulai R, Korom I, Varga E, Dobozy A. Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas. Br J Dermatol 2003; 149:662-3.
7. Kesmodel SB, Karakousis GC, Botbyl JD, et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 2005; 12:449-58.
8. Koskivuo I, Suominen E, Niinikoski J, Talve L. Sentinel node metastasectomy in thin ≤1-mm melanoma. Langenbecks Arch Chir (in press).
9. Karakousis GC, Gimotty PA, Kesmodel SB, et al. Prognostic factors for nodal failure in patients with thin melanomas. Ann Surg Oncol 2005; 12(Suppl):S18-9.
10. Sondak VK, Taylor JM, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004; 11:247-58.
11. Agnese DM, Abdessalam SF, Burak WE Jr, Magro CM, Pozderac RV, Walker MJ. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003; 134:542-7; discussion 547-8.